Search

Your search keyword '"Gram, Inger T."' showing total 90 results

Search Constraints

Start Over You searched for: Author "Gram, Inger T." Remove constraint Author: "Gram, Inger T." Database MEDLINE Remove constraint Database: MEDLINE
90 results on '"Gram, Inger T."'

Search Results

1. Pre-diagnostic plasma advanced glycation end-products and soluble receptor for advanced glycation end-products and mortality in colorectal cancer patients.

2. Smoking Cessation and Short- and Longer-Term Mortality.

3. Prediagnostic serum glyceraldehyde-derived advanced glycation end products and mortality among colorectal cancer patients.

4. Smoking and pancreatic cancer: a sex-specific analysis in the Multiethnic Cohort study.

5. Factors associated with predictors of smoking cessation from a Norwegian internet-based smoking cessation intervention study.

6. Cigarette Smoking and Endometrial Cancer Risk: Observational and Mendelian Randomization Analyses.

7. Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer.

8. Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohort.

9. Never-smokers and the fraction of breast cancer attributable to second-hand smoke from parents during childhood: the Norwegian Women and Cancer Study 1991-2018.

10. Long-term weight change and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.

11. Dietary Intake of Advanced Glycation End Products (AGEs) and Mortality among Individuals with Colorectal Cancer.

12. Inflammatory potential of the diet and risk of breast cancer in the European Investigation into Cancer and Nutrition (EPIC) study.

13. Polyphenol Intake and Epithelial Ovarian Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study.

14. Prospective analysis of circulating metabolites and endometrial cancer risk.

15. Causal Effects of Lifetime Smoking on Breast and Colorectal Cancer Risk: Mendelian Randomization Study.

16. Red Blood Cell Fatty Acids and Risk of Colorectal Cancer in The European Prospective Investigation into Cancer and Nutrition (EPIC).

17. Risk Prediction for Renal Cell Carcinoma: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Prospective Cohort Study.

18. Soluble Receptor for Advanced Glycation End-products (sRAGE) and Colorectal Cancer Risk: A Case-Control Study Nested within a European Prospective Cohort.

19. Association of prediagnostic vitamin D status with mortality among colorectal cancer patients differs by common, inherited vitamin D-binding protein isoforms.

20. Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the EPIC cohort.

21. Ovarian Cancer Risk Factor Associations by Primary Anatomic Site: The Ovarian Cancer Cohort Consortium.

22. Dietary and Circulating Fatty Acids and Ovarian Cancer Risk in the European Prospective Investigation into Cancer and Nutrition.

23. Adult weight change and premenopausal breast cancer risk: A prospective pooled analysis of data from 628,463 women.

24. Menstrual Factors, Reproductive History, Hormone Use, and Urothelial Carcinoma Risk: A Prospective Study in the EPIC Cohort.

25. Antibody Responses to Helicobacter pylori and Risk of Developing Colorectal Cancer in a European Cohort.

26. Smoking-Related Risks of Colorectal Cancer by Anatomical Subsite and Sex.

27. The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3).

28. Development and validation of circulating CA125 prediction models in postmenopausal women.

29. High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort Consortium.

30. Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort Consortium.

31. Smoking and breast cancer risk by race/ethnicity and oestrogen and progesterone receptor status: the Multiethnic Cohort (MEC) study.

32. Breast Cancer Risk After Recent Childbirth: A Pooled Analysis of 15 Prospective Studies.

33. Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition.

34. Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation.

35. Anti-CA15.3 and Anti-CA125 Antibodies and Ovarian Cancer Risk: Results from the EPIC Cohort.

36. Sex Differences in Risk of Smoking-Associated Lung Cancer: Results From a Cohort of 600,000 Norwegians.

37. The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium.

38. Pooled analysis of active cigarette smoking and invasive breast cancer risk in 14 cohort studies.

39. Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort.

40. The fraction of breast cancer attributable to smoking: The Norwegian women and cancer study 1991-2012.

41. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium.

42. Combined effects of smoking and HPV16 in oropharyngeal cancer.

43. Correction: The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort.

44. The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort.

45. An epidemiological model for prediction of endometrial cancer risk in Europe.

46. Smoking and Risk of Breast Cancer in a Racially/Ethnically Diverse Population of Mainly Women Who Do Not Drink Alcohol: The MEC Study.

47. Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort.

48. Investigation of dietary factors and endometrial cancer risk using a nutrient-wide association study approach in the EPIC and Nurses' Health Study (NHS) and NHSII.

49. Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition.

50. Dietary intake of acrylamide and epithelial ovarian cancer risk in the european prospective investigation into cancer and nutrition (EPIC) cohort.

Catalog

Books, media, physical & digital resources